-- Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...
NIL collective operator Blueprint Sports ran nearly $35 million in college athlete NIL contributions in 2024 through its companion charity, according to newly filed federal tax records. The BPS ...
-- ASH data reinforce survival benefits of front-line AYVAKIT® (avapritinib) use in patients with advanced SM -- -- Bone density analyses reported in patients with advanced SM underscore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results